Torrent Pharmaceuticals Q4 Profit Declines 27% Amid Revenue Growth and Exceptional Costs
1 hour agoBusiness
29LENS
5 SourcesTorrent, Valencia, Spain
TBNthebalanced.news

Torrent Pharmaceuticals Q4 Profit Declines 27% Amid Revenue Growth and Exceptional Costs

Torrent Pharmaceuticals reported a 27% decline in Q4 FY26 net profit to Rs 364 crore, mainly due to Rs 66 crore in exceptional items and increased expenses following the JB Pharmaceuticals acquisition. Despite this, revenue rose about 42% year-on-year to Rs 4,197 crore, driven by strong growth in India (43%), Brazil (30%), and the US (31%). For FY26, net profit increased to Rs 2,138 crore from Rs 1,911 crore, with total revenue reaching nearly Rs 14,000 crore, reflecting overall business expansion.

Political Bias
0%100%0%
Sentiment
55%
AI analysis of 5 sources · Published under editorial oversight by The Balanced News
Analysed 22 May 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Political bias across 5 sources
● Left 0%● Center 100%● Right 0%

The article group presents a primarily business-focused perspective, emphasizing financial results without political framing. Coverage includes company statements and regulatory filings, reflecting corporate and market viewpoints. There is no evident political bias, as the reports focus on factual financial performance and operational details, with no partisan commentary or ideological interpretation.

Sentiment — Neutral (55/100)

The overall sentiment is mixed, combining positive aspects like significant revenue growth and increased annual profit with negative elements such as a quarterly profit decline due to exceptional expenses and integration costs. The tone remains neutral and factual, highlighting both achievements and challenges without emotive language or subjective judgment.

How 5 sources covered this story

Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.

SourceTheir headlineBiasSentiment
businessstandardTorrent Pharma Q4 profit falls 21.9 on high expenses despite revenue boostCenterNeutral
freepressjournalTorrent Pharmaceuticals Q4 Profit Falls 27 To 364 Crore On Exceptional Items, Revenue Jumps 42CenterNeutral
businessstandardTorrent Pharmaceuticals consolidated net profit declines 26.91 in the March 2026 quarterCenterNeutral
businessstandardTorrent Pharma Q4 profit falls 27 to 364 cr due to exceptional item outgoCenterNeutral
news18Torrent Pharma Q4 profit down 27 pc at Rs 364 crCenterNeutral

Coverage timeline

news18 broke this story on 22 May, 01:06 pm. Other outlets followed.

  1. 1
    news1822 May, 01:06 pm
    Torrent Pharma Q4 profit down 27 pc at Rs 364 cr
  2. 2
    businessstandard22 May, 01:16 pm
    Torrent Pharma Q4 profit falls 27 to 364 cr due to exceptional item outgo
  3. 3
    businessstandard22 May, 01:35 pm
    Torrent Pharmaceuticals consolidated net profit declines 26.91 in the March 2026 quarter
  4. 4
    freepressjournal22 May, 01:38 pm
    Torrent Pharmaceuticals Q4 Profit Falls 27 To 364 Crore On Exceptional Items, Revenue Jumps 42
  5. 5
    businessstandard22 May, 01:49 pm
    Torrent Pharma Q4 profit falls 21.9 on high expenses despite revenue boost

Lens Score breakdown

29/100
Public interest0/100
Coverage gap90%

Well-covered story — coverage matches public importance.

Who's involved

Institutions and figures named across source coverage.

Corporate
Torrent Pharmaceuticals Ltd

Story context

Category
Business
Location
Torrent, Valencia, Spain
Sources analysed
5
Last analysed
22 May 2026
Key entities
Torrent PharmaceuticalsCroreIndian rupeeTorrent, ValenciaIndiaBrazilNet incomeRevenueDividendSun PharmaPage IndustriesReliance Power